Picks for 12/4/20

Watching some new tickers this morning in addition to some picked previously.


I am watching:


XTNT - Watching this for a potential swing trade. I like this chart. The MACD is crossing and yesterday there was a small gap up to open. I like the multiple bottom in early November around the $1.10 range which established support. I would like to see it break $1.42 to enter for a swing.


$1.62 first target

$1.79 second target

EMKR - I picked this on 12/2 and it has moved as expected. I am going to stick with this one for a swing.



I am also closely watching:


CEMI. I added to my swing position in the premarket after it sold off heavily. The sell-off was due to a response from the FDA that states: "THAT THE FDA HAS DETERMINED THAT REVIEW OF IGM/IGG EUA REQUEST IS NOT A PRIORITY" In my opinion, the sell off is not justified.


BCRX - BioCryst Announced FDA Approval of ORLADEYO™. This may offer some intraday trading opportunities.


VERI and JMIA continue to look strong and will likely present intraday opportunities. ADIL and EGAN still on watch.



61 views0 comments

Recent Posts

See All

Picks for 12/7/21

CNDT - MACD is crossing and the price has consolidated for several days at the 4.96 level, which has acted as a key support/resistance level in the past. The most recent candle tested the uptrend lin

Picks for 12/6/21

AAPL, WBA, SXOOF NLST - Market overreaction to the case vs Samung may create an opportunity to add shares.

Picks for 12/3/21

CDEV - It looks like it could be in the early stages of a reversal as the most recent candle tested the 200 sma and closed above the .50 fibonacci level. A tight stop is necessary until the reversal